nodes	percent_of_prediction	percent_of_DWPC	metapath
Mexiletine—AHR—Flutamide—prostate cancer	0.248	0.575	CbGbCtD
Mexiletine—AHR—prostate cancer	0.234	0.661	CbGaD
Mexiletine—CYP2E1—prostate cancer	0.0737	0.208	CbGaD
Mexiletine—CYP3A4—prostate cancer	0.0464	0.131	CbGaD
Mexiletine—CYP2E1—Estrone—prostate cancer	0.0145	0.0336	CbGbCtD
Mexiletine—CYP2B6—Estrone—prostate cancer	0.0143	0.0332	CbGbCtD
Mexiletine—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0139	0.0324	CbGbCtD
Mexiletine—CYP2B6—Ethinyl Estradiol—prostate cancer	0.0127	0.0296	CbGbCtD
Mexiletine—CYP1A2—Flutamide—prostate cancer	0.0116	0.0269	CbGbCtD
Mexiletine—CYP2D6—Bicalutamide—prostate cancer	0.0115	0.0267	CbGbCtD
Mexiletine—CYP2D6—Abiraterone—prostate cancer	0.00953	0.0222	CbGbCtD
Mexiletine—CYP2E1—Mitoxantrone—prostate cancer	0.0086	0.02	CbGbCtD
Mexiletine—CYP1A2—Estrone—prostate cancer	0.00837	0.0194	CbGbCtD
Mexiletine—CYP3A4—Bicalutamide—prostate cancer	0.00732	0.017	CbGbCtD
Mexiletine—CYP3A4—Estramustine—prostate cancer	0.0068	0.0158	CbGbCtD
Mexiletine—CYP3A4—Flutamide—prostate cancer	0.00606	0.0141	CbGbCtD
Mexiletine—CYP3A4—Abiraterone—prostate cancer	0.00606	0.0141	CbGbCtD
Mexiletine—CYP1A2—Conjugated Estrogens—prostate cancer	0.00547	0.0127	CbGbCtD
Mexiletine—CYP2E1—Etoposide—prostate cancer	0.00542	0.0126	CbGbCtD
Mexiletine—CYP1A2—Estradiol—prostate cancer	0.0048	0.0112	CbGbCtD
Mexiletine—CYP3A4—Cabazitaxel—prostate cancer	0.00448	0.0104	CbGbCtD
Mexiletine—CYP3A4—Estrone—prostate cancer	0.00438	0.0102	CbGbCtD
Mexiletine—CYP3A4—Ethinyl Estradiol—prostate cancer	0.00391	0.00908	CbGbCtD
Mexiletine—CYP2B6—Doxorubicin—prostate cancer	0.00365	0.00848	CbGbCtD
Mexiletine—CYP1A2—Etoposide—prostate cancer	0.00314	0.00729	CbGbCtD
Mexiletine—CYP3A4—Conjugated Estrogens—prostate cancer	0.00287	0.00667	CbGbCtD
Mexiletine—CYP3A4—Mitoxantrone—prostate cancer	0.00261	0.00606	CbGbCtD
Mexiletine—CYP3A4—Estradiol—prostate cancer	0.00252	0.00585	CbGbCtD
Mexiletine—CYP3A4—Prednisone—prostate cancer	0.00216	0.00503	CbGbCtD
Mexiletine—CYP2D6—Doxorubicin—prostate cancer	0.00176	0.0041	CbGbCtD
Mexiletine—CYP3A4—Etoposide—prostate cancer	0.00164	0.00382	CbGbCtD
Mexiletine—CYP1A2—urine—prostate cancer	0.00152	0.0764	CbGeAlD
Mexiletine—CYP3A4—Docetaxel—prostate cancer	0.0015	0.0035	CbGbCtD
Mexiletine—SCN9A—prostate gland—prostate cancer	0.0015	0.0753	CbGeAlD
Mexiletine—AHR—prostate gland—prostate cancer	0.00146	0.0735	CbGeAlD
Mexiletine—CYP2E1—urine—prostate cancer	0.00137	0.0687	CbGeAlD
Mexiletine—SCN4A—prostate gland—prostate cancer	0.00134	0.0672	CbGeAlD
Mexiletine—AHR—seminal vesicle—prostate cancer	0.00124	0.0621	CbGeAlD
Mexiletine—CYP3A4—Doxorubicin—prostate cancer	0.00112	0.00261	CbGbCtD
Mexiletine—CYP3A4—urine—prostate cancer	0.0011	0.0553	CbGeAlD
Mexiletine—CYP2D6—urine—prostate cancer	0.00108	0.0544	CbGeAlD
Mexiletine—AHR—urethra—prostate cancer	0.00098	0.0492	CbGeAlD
Mexiletine—SCN4A—renal system—prostate cancer	0.000912	0.0458	CbGeAlD
Mexiletine—AHR—bone marrow—prostate cancer	0.000754	0.0379	CbGeAlD
Mexiletine—SCN9A—testis—prostate cancer	0.000661	0.0332	CbGeAlD
Mexiletine—AHR—testis—prostate cancer	0.000645	0.0324	CbGeAlD
Mexiletine—SCN4A—testis—prostate cancer	0.00059	0.0296	CbGeAlD
Mexiletine—CYP2E1—prostate gland—prostate cancer	0.000492	0.0247	CbGeAlD
Mexiletine—SCN9A—lymph node—prostate cancer	0.000479	0.024	CbGeAlD
Mexiletine—AHR—lymph node—prostate cancer	0.000467	0.0235	CbGeAlD
Mexiletine—CYP2E1—seminal vesicle—prostate cancer	0.000416	0.0209	CbGeAlD
Mexiletine—CYP1A2—renal system—prostate cancer	0.000372	0.0187	CbGeAlD
Mexiletine—SCN10A—lymph node—prostate cancer	0.000365	0.0183	CbGeAlD
Mexiletine—CYP2B6—renal system—prostate cancer	0.000357	0.0179	CbGeAlD
Mexiletine—CYP2E1—renal system—prostate cancer	0.000335	0.0168	CbGeAlD
Mexiletine—CYP2E1—urethra—prostate cancer	0.000329	0.0165	CbGeAlD
Mexiletine—CYP3A4—renal system—prostate cancer	0.00027	0.0135	CbGeAlD
Mexiletine—CYP2D6—renal system—prostate cancer	0.000265	0.0133	CbGeAlD
Mexiletine—CYP2B6—testis—prostate cancer	0.000231	0.0116	CbGeAlD
Mexiletine—CYP2E1—testis—prostate cancer	0.000217	0.0109	CbGeAlD
Mexiletine—CYP2D6—testis—prostate cancer	0.000171	0.0086	CbGeAlD
Mexiletine—Arrhythmia—Prednisone—prostate cancer	5.44e-05	0.00048	CcSEcCtD
Mexiletine—Palpitations—Docetaxel—prostate cancer	5.43e-05	0.000479	CcSEcCtD
Mexiletine—Paraesthesia—Etoposide—prostate cancer	5.42e-05	0.000478	CcSEcCtD
Mexiletine—Loss of consciousness—Docetaxel—prostate cancer	5.4e-05	0.000477	CcSEcCtD
Mexiletine—Pancreatitis—Doxorubicin—prostate cancer	5.39e-05	0.000476	CcSEcCtD
Mexiletine—Dyspnoea—Etoposide—prostate cancer	5.38e-05	0.000475	CcSEcCtD
Mexiletine—Alopecia—Prednisone—prostate cancer	5.38e-05	0.000475	CcSEcCtD
Mexiletine—Malaise—Capecitabine—prostate cancer	5.36e-05	0.000474	CcSEcCtD
Mexiletine—Somnolence—Etoposide—prostate cancer	5.36e-05	0.000474	CcSEcCtD
Mexiletine—Angina pectoris—Doxorubicin—prostate cancer	5.36e-05	0.000473	CcSEcCtD
Mexiletine—Hypersensitivity—Mitoxantrone—prostate cancer	5.34e-05	0.000472	CcSEcCtD
Mexiletine—Syncope—Capecitabine—prostate cancer	5.33e-05	0.000471	CcSEcCtD
Mexiletine—Diarrhoea—Estradiol—prostate cancer	5.32e-05	0.00047	CcSEcCtD
Mexiletine—Leukopenia—Capecitabine—prostate cancer	5.32e-05	0.00047	CcSEcCtD
Mexiletine—Convulsion—Docetaxel—prostate cancer	5.32e-05	0.00047	CcSEcCtD
Mexiletine—Hypertension—Docetaxel—prostate cancer	5.3e-05	0.000468	CcSEcCtD
Mexiletine—Drowsiness—Epirubicin—prostate cancer	5.3e-05	0.000468	CcSEcCtD
Mexiletine—Stevens-Johnson syndrome—Epirubicin—prostate cancer	5.26e-05	0.000464	CcSEcCtD
Mexiletine—Palpitations—Capecitabine—prostate cancer	5.25e-05	0.000464	CcSEcCtD
Mexiletine—Chest pain—Docetaxel—prostate cancer	5.23e-05	0.000462	CcSEcCtD
Mexiletine—Arthralgia—Docetaxel—prostate cancer	5.23e-05	0.000462	CcSEcCtD
Mexiletine—Loss of consciousness—Capecitabine—prostate cancer	5.23e-05	0.000462	CcSEcCtD
Mexiletine—Asthenia—Mitoxantrone—prostate cancer	5.2e-05	0.00046	CcSEcCtD
Mexiletine—Fatigue—Etoposide—prostate cancer	5.2e-05	0.000459	CcSEcCtD
Mexiletine—Constipation—Etoposide—prostate cancer	5.16e-05	0.000456	CcSEcCtD
Mexiletine—Pain—Etoposide—prostate cancer	5.16e-05	0.000456	CcSEcCtD
Mexiletine—Dizziness—Estradiol—prostate cancer	5.15e-05	0.000455	CcSEcCtD
Mexiletine—Neutropenia—Doxorubicin—prostate cancer	5.14e-05	0.000454	CcSEcCtD
Mexiletine—Hypertension—Capecitabine—prostate cancer	5.13e-05	0.000454	CcSEcCtD
Mexiletine—Dry mouth—Docetaxel—prostate cancer	5.11e-05	0.000452	CcSEcCtD
Mexiletine—Arthralgia—Capecitabine—prostate cancer	5.06e-05	0.000447	CcSEcCtD
Mexiletine—Chest pain—Capecitabine—prostate cancer	5.06e-05	0.000447	CcSEcCtD
Mexiletine—Confusional state—Docetaxel—prostate cancer	5.05e-05	0.000446	CcSEcCtD
Mexiletine—Oedema—Docetaxel—prostate cancer	5.01e-05	0.000443	CcSEcCtD
Mexiletine—Discomfort—Capecitabine—prostate cancer	5e-05	0.000442	CcSEcCtD
Mexiletine—Vision blurred—Prednisone—prostate cancer	4.99e-05	0.000441	CcSEcCtD
Mexiletine—Feeling abnormal—Etoposide—prostate cancer	4.97e-05	0.000439	CcSEcCtD
Mexiletine—Diarrhoea—Mitoxantrone—prostate cancer	4.96e-05	0.000438	CcSEcCtD
Mexiletine—Dry mouth—Capecitabine—prostate cancer	4.95e-05	0.000437	CcSEcCtD
Mexiletine—Vomiting—Estradiol—prostate cancer	4.95e-05	0.000437	CcSEcCtD
Mexiletine—Agranulocytosis—Epirubicin—prostate cancer	4.95e-05	0.000437	CcSEcCtD
Mexiletine—Gastrointestinal pain—Etoposide—prostate cancer	4.93e-05	0.000436	CcSEcCtD
Mexiletine—Shock—Docetaxel—prostate cancer	4.93e-05	0.000436	CcSEcCtD
Mexiletine—Ill-defined disorder—Prednisone—prostate cancer	4.91e-05	0.000434	CcSEcCtD
Mexiletine—Thrombocytopenia—Docetaxel—prostate cancer	4.91e-05	0.000434	CcSEcCtD
Mexiletine—Rash—Estradiol—prostate cancer	4.91e-05	0.000433	CcSEcCtD
Mexiletine—Drowsiness—Doxorubicin—prostate cancer	4.9e-05	0.000433	CcSEcCtD
Mexiletine—Dermatitis—Estradiol—prostate cancer	4.9e-05	0.000433	CcSEcCtD
Mexiletine—Confusional state—Capecitabine—prostate cancer	4.89e-05	0.000432	CcSEcCtD
Mexiletine—Headache—Estradiol—prostate cancer	4.88e-05	0.000431	CcSEcCtD
Mexiletine—Stevens-Johnson syndrome—Doxorubicin—prostate cancer	4.86e-05	0.00043	CcSEcCtD
Mexiletine—Oedema—Capecitabine—prostate cancer	4.85e-05	0.000429	CcSEcCtD
Mexiletine—Bradycardia—Epirubicin—prostate cancer	4.84e-05	0.000428	CcSEcCtD
Mexiletine—Malaise—Prednisone—prostate cancer	4.78e-05	0.000422	CcSEcCtD
Mexiletine—Shock—Capecitabine—prostate cancer	4.77e-05	0.000422	CcSEcCtD
Mexiletine—Body temperature increased—Etoposide—prostate cancer	4.77e-05	0.000421	CcSEcCtD
Mexiletine—Abdominal pain—Etoposide—prostate cancer	4.77e-05	0.000421	CcSEcCtD
Mexiletine—Hepatitis—Epirubicin—prostate cancer	4.76e-05	0.00042	CcSEcCtD
Mexiletine—Thrombocytopenia—Capecitabine—prostate cancer	4.75e-05	0.00042	CcSEcCtD
Mexiletine—Syncope—Prednisone—prostate cancer	4.75e-05	0.00042	CcSEcCtD
Mexiletine—Hypoaesthesia—Epirubicin—prostate cancer	4.73e-05	0.000418	CcSEcCtD
Mexiletine—Pharyngitis—Epirubicin—prostate cancer	4.72e-05	0.000417	CcSEcCtD
Mexiletine—Hyperhidrosis—Capecitabine—prostate cancer	4.69e-05	0.000414	CcSEcCtD
Mexiletine—Hypotension—Docetaxel—prostate cancer	4.68e-05	0.000414	CcSEcCtD
Mexiletine—Loss of consciousness—Prednisone—prostate cancer	4.66e-05	0.000411	CcSEcCtD
Mexiletine—Nausea—Estradiol—prostate cancer	4.62e-05	0.000408	CcSEcCtD
Mexiletine—Vomiting—Mitoxantrone—prostate cancer	4.61e-05	0.000407	CcSEcCtD
Mexiletine—Convulsion—Prednisone—prostate cancer	4.59e-05	0.000405	CcSEcCtD
Mexiletine—Visual impairment—Epirubicin—prostate cancer	4.59e-05	0.000405	CcSEcCtD
Mexiletine—Agranulocytosis—Doxorubicin—prostate cancer	4.58e-05	0.000404	CcSEcCtD
Mexiletine—Hypertension—Prednisone—prostate cancer	4.57e-05	0.000404	CcSEcCtD
Mexiletine—Rash—Mitoxantrone—prostate cancer	4.57e-05	0.000404	CcSEcCtD
Mexiletine—Dermatitis—Mitoxantrone—prostate cancer	4.57e-05	0.000404	CcSEcCtD
Mexiletine—Musculoskeletal discomfort—Docetaxel—prostate cancer	4.57e-05	0.000403	CcSEcCtD
Mexiletine—Headache—Mitoxantrone—prostate cancer	4.54e-05	0.000401	CcSEcCtD
Mexiletine—Hypotension—Capecitabine—prostate cancer	4.53e-05	0.000401	CcSEcCtD
Mexiletine—Arthralgia—Prednisone—prostate cancer	4.51e-05	0.000398	CcSEcCtD
Mexiletine—Paraesthesia—Docetaxel—prostate cancer	4.5e-05	0.000398	CcSEcCtD
Mexiletine—Erythema multiforme—Epirubicin—prostate cancer	4.5e-05	0.000397	CcSEcCtD
Mexiletine—Bradycardia—Doxorubicin—prostate cancer	4.48e-05	0.000396	CcSEcCtD
Mexiletine—Dyspnoea—Docetaxel—prostate cancer	4.47e-05	0.000395	CcSEcCtD
Mexiletine—Somnolence—Docetaxel—prostate cancer	4.46e-05	0.000394	CcSEcCtD
Mexiletine—Discomfort—Prednisone—prostate cancer	4.46e-05	0.000394	CcSEcCtD
Mexiletine—Hypersensitivity—Etoposide—prostate cancer	4.44e-05	0.000393	CcSEcCtD
Mexiletine—Tinnitus—Epirubicin—prostate cancer	4.44e-05	0.000392	CcSEcCtD
Mexiletine—Musculoskeletal discomfort—Capecitabine—prostate cancer	4.42e-05	0.000391	CcSEcCtD
Mexiletine—Dyspepsia—Docetaxel—prostate cancer	4.41e-05	0.00039	CcSEcCtD
Mexiletine—Hepatitis—Doxorubicin—prostate cancer	4.4e-05	0.000389	CcSEcCtD
Mexiletine—Hypoaesthesia—Doxorubicin—prostate cancer	4.38e-05	0.000387	CcSEcCtD
Mexiletine—Pharyngitis—Doxorubicin—prostate cancer	4.37e-05	0.000386	CcSEcCtD
Mexiletine—Paraesthesia—Capecitabine—prostate cancer	4.36e-05	0.000385	CcSEcCtD
Mexiletine—Asthenia—Etoposide—prostate cancer	4.33e-05	0.000382	CcSEcCtD
Mexiletine—Dyspnoea—Capecitabine—prostate cancer	4.33e-05	0.000382	CcSEcCtD
Mexiletine—Oedema—Prednisone—prostate cancer	4.32e-05	0.000382	CcSEcCtD
Mexiletine—Fatigue—Docetaxel—prostate cancer	4.32e-05	0.000382	CcSEcCtD
Mexiletine—Nausea—Mitoxantrone—prostate cancer	4.31e-05	0.00038	CcSEcCtD
Mexiletine—Pain—Docetaxel—prostate cancer	4.29e-05	0.000379	CcSEcCtD
Mexiletine—Constipation—Docetaxel—prostate cancer	4.29e-05	0.000379	CcSEcCtD
Mexiletine—Dyspepsia—Capecitabine—prostate cancer	4.27e-05	0.000377	CcSEcCtD
Mexiletine—Shock—Prednisone—prostate cancer	4.25e-05	0.000376	CcSEcCtD
Mexiletine—Arrhythmia—Epirubicin—prostate cancer	4.25e-05	0.000376	CcSEcCtD
Mexiletine—Visual impairment—Doxorubicin—prostate cancer	4.24e-05	0.000375	CcSEcCtD
Mexiletine—Alopecia—Epirubicin—prostate cancer	4.21e-05	0.000371	CcSEcCtD
Mexiletine—Fatigue—Capecitabine—prostate cancer	4.18e-05	0.00037	CcSEcCtD
Mexiletine—Hyperhidrosis—Prednisone—prostate cancer	4.18e-05	0.000369	CcSEcCtD
Mexiletine—Erythema multiforme—Doxorubicin—prostate cancer	4.16e-05	0.000368	CcSEcCtD
Mexiletine—Pain—Capecitabine—prostate cancer	4.15e-05	0.000367	CcSEcCtD
Mexiletine—Constipation—Capecitabine—prostate cancer	4.15e-05	0.000367	CcSEcCtD
Mexiletine—Feeling abnormal—Docetaxel—prostate cancer	4.13e-05	0.000365	CcSEcCtD
Mexiletine—Diarrhoea—Etoposide—prostate cancer	4.13e-05	0.000365	CcSEcCtD
Mexiletine—Tinnitus—Doxorubicin—prostate cancer	4.11e-05	0.000363	CcSEcCtD
Mexiletine—Gastrointestinal pain—Docetaxel—prostate cancer	4.1e-05	0.000362	CcSEcCtD
Mexiletine—Tension—Epirubicin—prostate cancer	4.07e-05	0.000359	CcSEcCtD
Mexiletine—Dysgeusia—Epirubicin—prostate cancer	4.06e-05	0.000358	CcSEcCtD
Mexiletine—Nervousness—Epirubicin—prostate cancer	4.02e-05	0.000355	CcSEcCtD
Mexiletine—Feeling abnormal—Capecitabine—prostate cancer	4e-05	0.000353	CcSEcCtD
Mexiletine—Dizziness—Etoposide—prostate cancer	3.99e-05	0.000352	CcSEcCtD
Mexiletine—Muscle spasms—Epirubicin—prostate cancer	3.98e-05	0.000352	CcSEcCtD
Mexiletine—Gastrointestinal pain—Capecitabine—prostate cancer	3.97e-05	0.000351	CcSEcCtD
Mexiletine—Body temperature increased—Docetaxel—prostate cancer	3.96e-05	0.00035	CcSEcCtD
Mexiletine—Abdominal pain—Docetaxel—prostate cancer	3.96e-05	0.00035	CcSEcCtD
Mexiletine—Musculoskeletal discomfort—Prednisone—prostate cancer	3.94e-05	0.000348	CcSEcCtD
Mexiletine—Arrhythmia—Doxorubicin—prostate cancer	3.93e-05	0.000347	CcSEcCtD
Mexiletine—Vision blurred—Epirubicin—prostate cancer	3.9e-05	0.000345	CcSEcCtD
Mexiletine—Alopecia—Doxorubicin—prostate cancer	3.89e-05	0.000344	CcSEcCtD
Mexiletine—Paraesthesia—Prednisone—prostate cancer	3.88e-05	0.000343	CcSEcCtD
Mexiletine—Ill-defined disorder—Epirubicin—prostate cancer	3.84e-05	0.00034	CcSEcCtD
Mexiletine—Body temperature increased—Capecitabine—prostate cancer	3.84e-05	0.000339	CcSEcCtD
Mexiletine—Abdominal pain—Capecitabine—prostate cancer	3.84e-05	0.000339	CcSEcCtD
Mexiletine—Vomiting—Etoposide—prostate cancer	3.83e-05	0.000339	CcSEcCtD
Mexiletine—Dyspepsia—Prednisone—prostate cancer	3.81e-05	0.000336	CcSEcCtD
Mexiletine—Rash—Etoposide—prostate cancer	3.8e-05	0.000336	CcSEcCtD
Mexiletine—Dermatitis—Etoposide—prostate cancer	3.8e-05	0.000336	CcSEcCtD
Mexiletine—Headache—Etoposide—prostate cancer	3.78e-05	0.000334	CcSEcCtD
Mexiletine—Tension—Doxorubicin—prostate cancer	3.76e-05	0.000332	CcSEcCtD
Mexiletine—Dysgeusia—Doxorubicin—prostate cancer	3.75e-05	0.000332	CcSEcCtD
Mexiletine—Malaise—Epirubicin—prostate cancer	3.74e-05	0.00033	CcSEcCtD
Mexiletine—Fatigue—Prednisone—prostate cancer	3.73e-05	0.000329	CcSEcCtD
Mexiletine—Nervousness—Doxorubicin—prostate cancer	3.72e-05	0.000329	CcSEcCtD
Mexiletine—Syncope—Epirubicin—prostate cancer	3.72e-05	0.000328	CcSEcCtD
Mexiletine—Leukopenia—Epirubicin—prostate cancer	3.71e-05	0.000328	CcSEcCtD
Mexiletine—Constipation—Prednisone—prostate cancer	3.7e-05	0.000327	CcSEcCtD
Mexiletine—Hypersensitivity—Docetaxel—prostate cancer	3.69e-05	0.000326	CcSEcCtD
Mexiletine—Muscle spasms—Doxorubicin—prostate cancer	3.69e-05	0.000326	CcSEcCtD
Mexiletine—Palpitations—Epirubicin—prostate cancer	3.66e-05	0.000323	CcSEcCtD
Mexiletine—Loss of consciousness—Epirubicin—prostate cancer	3.64e-05	0.000322	CcSEcCtD
Mexiletine—Vision blurred—Doxorubicin—prostate cancer	3.61e-05	0.000319	CcSEcCtD
Mexiletine—Asthenia—Docetaxel—prostate cancer	3.6e-05	0.000318	CcSEcCtD
Mexiletine—Convulsion—Epirubicin—prostate cancer	3.59e-05	0.000317	CcSEcCtD
Mexiletine—Nausea—Etoposide—prostate cancer	3.58e-05	0.000316	CcSEcCtD
Mexiletine—Hypertension—Epirubicin—prostate cancer	3.58e-05	0.000316	CcSEcCtD
Mexiletine—Hypersensitivity—Capecitabine—prostate cancer	3.58e-05	0.000316	CcSEcCtD
Mexiletine—Feeling abnormal—Prednisone—prostate cancer	3.56e-05	0.000315	CcSEcCtD
Mexiletine—Ill-defined disorder—Doxorubicin—prostate cancer	3.56e-05	0.000314	CcSEcCtD
Mexiletine—Gastrointestinal pain—Prednisone—prostate cancer	3.53e-05	0.000312	CcSEcCtD
Mexiletine—Chest pain—Epirubicin—prostate cancer	3.53e-05	0.000312	CcSEcCtD
Mexiletine—Arthralgia—Epirubicin—prostate cancer	3.53e-05	0.000312	CcSEcCtD
Mexiletine—Discomfort—Epirubicin—prostate cancer	3.48e-05	0.000308	CcSEcCtD
Mexiletine—Asthenia—Capecitabine—prostate cancer	3.48e-05	0.000308	CcSEcCtD
Mexiletine—Malaise—Doxorubicin—prostate cancer	3.46e-05	0.000305	CcSEcCtD
Mexiletine—Dry mouth—Epirubicin—prostate cancer	3.45e-05	0.000305	CcSEcCtD
Mexiletine—Syncope—Doxorubicin—prostate cancer	3.44e-05	0.000304	CcSEcCtD
Mexiletine—Leukopenia—Doxorubicin—prostate cancer	3.43e-05	0.000303	CcSEcCtD
Mexiletine—Diarrhoea—Docetaxel—prostate cancer	3.43e-05	0.000303	CcSEcCtD
Mexiletine—Body temperature increased—Prednisone—prostate cancer	3.42e-05	0.000302	CcSEcCtD
Mexiletine—Abdominal pain—Prednisone—prostate cancer	3.42e-05	0.000302	CcSEcCtD
Mexiletine—Confusional state—Epirubicin—prostate cancer	3.41e-05	0.000301	CcSEcCtD
Mexiletine—Palpitations—Doxorubicin—prostate cancer	3.39e-05	0.000299	CcSEcCtD
Mexiletine—Oedema—Epirubicin—prostate cancer	3.38e-05	0.000299	CcSEcCtD
Mexiletine—Loss of consciousness—Doxorubicin—prostate cancer	3.37e-05	0.000298	CcSEcCtD
Mexiletine—Shock—Epirubicin—prostate cancer	3.33e-05	0.000294	CcSEcCtD
Mexiletine—Convulsion—Doxorubicin—prostate cancer	3.32e-05	0.000293	CcSEcCtD
Mexiletine—Diarrhoea—Capecitabine—prostate cancer	3.32e-05	0.000293	CcSEcCtD
Mexiletine—Dizziness—Docetaxel—prostate cancer	3.31e-05	0.000293	CcSEcCtD
Mexiletine—Thrombocytopenia—Epirubicin—prostate cancer	3.31e-05	0.000292	CcSEcCtD
Mexiletine—Hypertension—Doxorubicin—prostate cancer	3.31e-05	0.000292	CcSEcCtD
Mexiletine—Hyperhidrosis—Epirubicin—prostate cancer	3.27e-05	0.000289	CcSEcCtD
Mexiletine—Chest pain—Doxorubicin—prostate cancer	3.26e-05	0.000288	CcSEcCtD
Mexiletine—Arthralgia—Doxorubicin—prostate cancer	3.26e-05	0.000288	CcSEcCtD
Mexiletine—Discomfort—Doxorubicin—prostate cancer	3.22e-05	0.000285	CcSEcCtD
Mexiletine—Dizziness—Capecitabine—prostate cancer	3.21e-05	0.000284	CcSEcCtD
Mexiletine—Dry mouth—Doxorubicin—prostate cancer	3.19e-05	0.000282	CcSEcCtD
Mexiletine—Vomiting—Docetaxel—prostate cancer	3.19e-05	0.000282	CcSEcCtD
Mexiletine—Hypersensitivity—Prednisone—prostate cancer	3.18e-05	0.000281	CcSEcCtD
Mexiletine—Rash—Docetaxel—prostate cancer	3.16e-05	0.000279	CcSEcCtD
Mexiletine—Hypotension—Epirubicin—prostate cancer	3.16e-05	0.000279	CcSEcCtD
Mexiletine—Dermatitis—Docetaxel—prostate cancer	3.16e-05	0.000279	CcSEcCtD
Mexiletine—Confusional state—Doxorubicin—prostate cancer	3.15e-05	0.000279	CcSEcCtD
Mexiletine—Headache—Docetaxel—prostate cancer	3.14e-05	0.000277	CcSEcCtD
Mexiletine—Oedema—Doxorubicin—prostate cancer	3.13e-05	0.000276	CcSEcCtD
Mexiletine—Asthenia—Prednisone—prostate cancer	3.1e-05	0.000274	CcSEcCtD
Mexiletine—Vomiting—Capecitabine—prostate cancer	3.09e-05	0.000273	CcSEcCtD
Mexiletine—Musculoskeletal discomfort—Epirubicin—prostate cancer	3.08e-05	0.000272	CcSEcCtD
Mexiletine—Shock—Doxorubicin—prostate cancer	3.08e-05	0.000272	CcSEcCtD
Mexiletine—Thrombocytopenia—Doxorubicin—prostate cancer	3.06e-05	0.000271	CcSEcCtD
Mexiletine—Rash—Capecitabine—prostate cancer	3.06e-05	0.00027	CcSEcCtD
Mexiletine—Dermatitis—Capecitabine—prostate cancer	3.06e-05	0.00027	CcSEcCtD
Mexiletine—Headache—Capecitabine—prostate cancer	3.04e-05	0.000269	CcSEcCtD
Mexiletine—Paraesthesia—Epirubicin—prostate cancer	3.04e-05	0.000268	CcSEcCtD
Mexiletine—Hyperhidrosis—Doxorubicin—prostate cancer	3.02e-05	0.000267	CcSEcCtD
Mexiletine—Dyspnoea—Epirubicin—prostate cancer	3.01e-05	0.000266	CcSEcCtD
Mexiletine—Somnolence—Epirubicin—prostate cancer	3.01e-05	0.000266	CcSEcCtD
Mexiletine—Nausea—Docetaxel—prostate cancer	2.98e-05	0.000263	CcSEcCtD
Mexiletine—Dyspepsia—Epirubicin—prostate cancer	2.98e-05	0.000263	CcSEcCtD
Mexiletine—Diarrhoea—Prednisone—prostate cancer	2.96e-05	0.000261	CcSEcCtD
Mexiletine—Hypotension—Doxorubicin—prostate cancer	2.92e-05	0.000258	CcSEcCtD
Mexiletine—Fatigue—Epirubicin—prostate cancer	2.91e-05	0.000258	CcSEcCtD
Mexiletine—Constipation—Epirubicin—prostate cancer	2.89e-05	0.000255	CcSEcCtD
Mexiletine—Pain—Epirubicin—prostate cancer	2.89e-05	0.000255	CcSEcCtD
Mexiletine—Nausea—Capecitabine—prostate cancer	2.88e-05	0.000255	CcSEcCtD
Mexiletine—Dizziness—Prednisone—prostate cancer	2.86e-05	0.000253	CcSEcCtD
Mexiletine—Musculoskeletal discomfort—Doxorubicin—prostate cancer	2.85e-05	0.000252	CcSEcCtD
Mexiletine—Paraesthesia—Doxorubicin—prostate cancer	2.81e-05	0.000248	CcSEcCtD
Mexiletine—Dyspnoea—Doxorubicin—prostate cancer	2.79e-05	0.000246	CcSEcCtD
Mexiletine—Feeling abnormal—Epirubicin—prostate cancer	2.79e-05	0.000246	CcSEcCtD
Mexiletine—Somnolence—Doxorubicin—prostate cancer	2.78e-05	0.000246	CcSEcCtD
Mexiletine—Gastrointestinal pain—Epirubicin—prostate cancer	2.76e-05	0.000244	CcSEcCtD
Mexiletine—Dyspepsia—Doxorubicin—prostate cancer	2.75e-05	0.000243	CcSEcCtD
Mexiletine—Vomiting—Prednisone—prostate cancer	2.75e-05	0.000243	CcSEcCtD
Mexiletine—Rash—Prednisone—prostate cancer	2.73e-05	0.000241	CcSEcCtD
Mexiletine—Dermatitis—Prednisone—prostate cancer	2.72e-05	0.000241	CcSEcCtD
Mexiletine—Headache—Prednisone—prostate cancer	2.71e-05	0.000239	CcSEcCtD
Mexiletine—Fatigue—Doxorubicin—prostate cancer	2.7e-05	0.000238	CcSEcCtD
Mexiletine—Pain—Doxorubicin—prostate cancer	2.68e-05	0.000236	CcSEcCtD
Mexiletine—Constipation—Doxorubicin—prostate cancer	2.68e-05	0.000236	CcSEcCtD
Mexiletine—Abdominal pain—Epirubicin—prostate cancer	2.67e-05	0.000236	CcSEcCtD
Mexiletine—Body temperature increased—Epirubicin—prostate cancer	2.67e-05	0.000236	CcSEcCtD
Mexiletine—Feeling abnormal—Doxorubicin—prostate cancer	2.58e-05	0.000228	CcSEcCtD
Mexiletine—Nausea—Prednisone—prostate cancer	2.57e-05	0.000227	CcSEcCtD
Mexiletine—Gastrointestinal pain—Doxorubicin—prostate cancer	2.56e-05	0.000226	CcSEcCtD
Mexiletine—Hypersensitivity—Epirubicin—prostate cancer	2.49e-05	0.00022	CcSEcCtD
Mexiletine—Body temperature increased—Doxorubicin—prostate cancer	2.47e-05	0.000218	CcSEcCtD
Mexiletine—Abdominal pain—Doxorubicin—prostate cancer	2.47e-05	0.000218	CcSEcCtD
Mexiletine—Asthenia—Epirubicin—prostate cancer	2.43e-05	0.000214	CcSEcCtD
Mexiletine—Diarrhoea—Epirubicin—prostate cancer	2.31e-05	0.000204	CcSEcCtD
Mexiletine—Hypersensitivity—Doxorubicin—prostate cancer	2.3e-05	0.000204	CcSEcCtD
Mexiletine—Asthenia—Doxorubicin—prostate cancer	2.24e-05	0.000198	CcSEcCtD
Mexiletine—Dizziness—Epirubicin—prostate cancer	2.24e-05	0.000198	CcSEcCtD
Mexiletine—Vomiting—Epirubicin—prostate cancer	2.15e-05	0.00019	CcSEcCtD
Mexiletine—Diarrhoea—Doxorubicin—prostate cancer	2.14e-05	0.000189	CcSEcCtD
Mexiletine—Rash—Epirubicin—prostate cancer	2.13e-05	0.000188	CcSEcCtD
Mexiletine—Dermatitis—Epirubicin—prostate cancer	2.13e-05	0.000188	CcSEcCtD
Mexiletine—Headache—Epirubicin—prostate cancer	2.12e-05	0.000187	CcSEcCtD
Mexiletine—Dizziness—Doxorubicin—prostate cancer	2.07e-05	0.000183	CcSEcCtD
Mexiletine—Nausea—Epirubicin—prostate cancer	2.01e-05	0.000177	CcSEcCtD
Mexiletine—Vomiting—Doxorubicin—prostate cancer	1.99e-05	0.000176	CcSEcCtD
Mexiletine—Rash—Doxorubicin—prostate cancer	1.97e-05	0.000174	CcSEcCtD
Mexiletine—Dermatitis—Doxorubicin—prostate cancer	1.97e-05	0.000174	CcSEcCtD
Mexiletine—Headache—Doxorubicin—prostate cancer	1.96e-05	0.000173	CcSEcCtD
Mexiletine—Nausea—Doxorubicin—prostate cancer	1.86e-05	0.000164	CcSEcCtD
Mexiletine—CYP2B6—Metabolism—NQO1—prostate cancer	3.29e-06	4e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism of lipids and lipoproteins—LPL—prostate cancer	3.27e-06	3.98e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—SLC22A1—prostate cancer	3.25e-06	3.94e-05	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—TH—prostate cancer	3.24e-06	3.94e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—TBXAS1—prostate cancer	3.23e-06	3.93e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—GSTA4—prostate cancer	3.23e-06	3.93e-05	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—NQO1—prostate cancer	3.22e-06	3.92e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—SULT1E1—prostate cancer	3.21e-06	3.9e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—SRD5A1—prostate cancer	3.21e-06	3.9e-05	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—CYP3A4—prostate cancer	3.21e-06	3.9e-05	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—TH—prostate cancer	3.18e-06	3.86e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—SULT2A1—prostate cancer	3.16e-06	3.84e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—prostate cancer	3.16e-06	3.84e-05	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—CYP1B1—prostate cancer	3.15e-06	3.83e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—GSTA2—prostate cancer	3.15e-06	3.83e-05	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—CYP3A4—prostate cancer	3.14e-06	3.82e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—ABCG5—prostate cancer	3.11e-06	3.78e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—SULT1A1—prostate cancer	3.11e-06	3.78e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—MED12—prostate cancer	3.11e-06	3.78e-05	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—CYP1B1—prostate cancer	3.09e-06	3.75e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—GNG5—prostate cancer	3.09e-06	3.75e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—ACSL4—prostate cancer	3.06e-06	3.72e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—HSD17B3—prostate cancer	3.06e-06	3.72e-05	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—GGT1—prostate cancer	3.05e-06	3.71e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—GSTA1—prostate cancer	3.04e-06	3.69e-05	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—NCOA1—prostate cancer	3.01e-06	3.66e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—GSTO1—prostate cancer	3.01e-06	3.65e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—NAT2—prostate cancer	3.01e-06	3.65e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—HSD3B2—prostate cancer	3.01e-06	3.65e-05	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—GGT1—prostate cancer	2.99e-06	3.64e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—NCOA3—prostate cancer	2.97e-06	3.61e-05	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—CYP19A1—prostate cancer	2.97e-06	3.6e-05	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—NCOA1—prostate cancer	2.95e-06	3.58e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—ARG2—prostate cancer	2.93e-06	3.57e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—PHGDH—prostate cancer	2.93e-06	3.57e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—UMPS—prostate cancer	2.93e-06	3.57e-05	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—CYP19A1—prostate cancer	2.9e-06	3.53e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	2.89e-06	3.51e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—PLCB2—prostate cancer	2.88e-06	3.5e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—CYP2C18—prostate cancer	2.88e-06	3.5e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—LRP2—prostate cancer	2.88e-06	3.5e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—LDHB—prostate cancer	2.88e-06	3.5e-05	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—RXRA—prostate cancer	2.86e-06	3.48e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—HPGDS—prostate cancer	2.84e-06	3.45e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—P4HB—prostate cancer	2.83e-06	3.43e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—CYP3A5—prostate cancer	2.83e-06	3.43e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—CYP2C19—prostate cancer	2.82e-06	3.43e-05	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—RXRA—prostate cancer	2.8e-06	3.41e-05	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—COMT—prostate cancer	2.76e-06	3.35e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—GSTT1—prostate cancer	2.75e-06	3.34e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—ACHE—prostate cancer	2.75e-06	3.34e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—SLC22A1—prostate cancer	2.75e-06	3.34e-05	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—GSTP1—prostate cancer	2.74e-06	3.33e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—UCP3—prostate cancer	2.73e-06	3.32e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—TCN2—prostate cancer	2.73e-06	3.32e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—PDHA1—prostate cancer	2.73e-06	3.32e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—GSTA3—prostate cancer	2.73e-06	3.32e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—CYP2A6—prostate cancer	2.72e-06	3.31e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	2.72e-06	3.3e-05	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—COMT—prostate cancer	2.7e-06	3.28e-05	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—ITPR1—prostate cancer	2.7e-06	3.28e-05	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—GSTP1—prostate cancer	2.69e-06	3.27e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—SULT2A1—prostate cancer	2.68e-06	3.26e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—AKR1C3—prostate cancer	2.65e-06	3.22e-05	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—ITPR1—prostate cancer	2.64e-06	3.21e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—MED12—prostate cancer	2.64e-06	3.2e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—PRKACB—prostate cancer	2.63e-06	3.2e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—GNG5—prostate cancer	2.62e-06	3.18e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—CYP17A1—prostate cancer	2.6e-06	3.17e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—HSD3B1—prostate cancer	2.6e-06	3.16e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—SLC22A3—prostate cancer	2.6e-06	3.16e-05	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—TYMS—prostate cancer	2.55e-06	3.1e-05	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—GSTM1—prostate cancer	2.52e-06	3.06e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—NCOA3—prostate cancer	2.52e-06	3.06e-05	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—TYMS—prostate cancer	2.5e-06	3.04e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—GSTA4—prostate cancer	2.5e-06	3.03e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—TBXAS1—prostate cancer	2.5e-06	3.03e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—NCOA2—prostate cancer	2.48e-06	3.02e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	2.48e-06	3.01e-05	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—LPL—prostate cancer	2.48e-06	3.01e-05	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—GSTM1—prostate cancer	2.47e-06	3e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—GSTA2—prostate cancer	2.43e-06	2.96e-05	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—LPL—prostate cancer	2.42e-06	2.95e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—HPGDS—prostate cancer	2.4e-06	2.92e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—SULT1A1—prostate cancer	2.4e-06	2.92e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—ABCG5—prostate cancer	2.4e-06	2.92e-05	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—CYP1A1—prostate cancer	2.39e-06	2.91e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—CYP2C19—prostate cancer	2.39e-06	2.9e-05	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—ERCC2—prostate cancer	2.37e-06	2.88e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—SLC5A5—prostate cancer	2.37e-06	2.88e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—GSTA1—prostate cancer	2.35e-06	2.85e-05	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—CYP1A1—prostate cancer	2.34e-06	2.85e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—GSTT1—prostate cancer	2.33e-06	2.83e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—ACHE—prostate cancer	2.33e-06	2.83e-05	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—ERCC2—prostate cancer	2.32e-06	2.82e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—NAT2—prostate cancer	2.32e-06	2.82e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—HSD3B2—prostate cancer	2.32e-06	2.82e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—GSTO1—prostate cancer	2.32e-06	2.82e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—CYP2E1—prostate cancer	2.31e-06	2.81e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—CYP2A6—prostate cancer	2.3e-06	2.8e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	2.3e-06	2.79e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—NQO1—prostate cancer	2.29e-06	2.78e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—TH—prostate cancer	2.25e-06	2.74e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—AKR1C3—prostate cancer	2.24e-06	2.72e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—CYP3A4—prostate cancer	2.23e-06	2.71e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—PRKACB—prostate cancer	2.23e-06	2.71e-05	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—MTHFR—prostate cancer	2.23e-06	2.71e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—PLCB2—prostate cancer	2.22e-06	2.7e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—LRP2—prostate cancer	2.22e-06	2.7e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—CYP2C18—prostate cancer	2.22e-06	2.7e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—CYP17A1—prostate cancer	2.21e-06	2.68e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—CYP1B1—prostate cancer	2.19e-06	2.66e-05	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—PPARA—prostate cancer	2.19e-06	2.66e-05	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—MTHFR—prostate cancer	2.18e-06	2.65e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—P4HB—prostate cancer	2.18e-06	2.65e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	2.18e-06	2.64e-05	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—PPARA—prostate cancer	2.14e-06	2.6e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—GGT1—prostate cancer	2.12e-06	2.58e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—SLC22A1—prostate cancer	2.12e-06	2.58e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—NCOA2—prostate cancer	2.1e-06	2.56e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—NCOA1—prostate cancer	2.09e-06	2.54e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—SULT2A1—prostate cancer	2.07e-06	2.51e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—CYP19A1—prostate cancer	2.06e-06	2.5e-05	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—CAV1—prostate cancer	2.06e-06	2.5e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—MED12—prostate cancer	2.03e-06	2.47e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—GNG5—prostate cancer	2.02e-06	2.45e-05	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—CAV1—prostate cancer	2.01e-06	2.45e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—SLC5A5—prostate cancer	2.01e-06	2.44e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—RXRA—prostate cancer	1.99e-06	2.42e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—CYP2E1—prostate cancer	1.96e-06	2.38e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—NCOA3—prostate cancer	1.94e-06	2.36e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—NQO1—prostate cancer	1.94e-06	2.35e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—COMT—prostate cancer	1.92e-06	2.33e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—TH—prostate cancer	1.91e-06	2.32e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—GSTP1—prostate cancer	1.91e-06	2.32e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	1.9e-06	2.31e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—CYP3A4—prostate cancer	1.89e-06	2.3e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	1.88e-06	2.28e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—ITPR1—prostate cancer	1.88e-06	2.28e-05	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—PIK3CG—prostate cancer	1.87e-06	2.28e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—CYP1B1—prostate cancer	1.86e-06	2.26e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—HPGDS—prostate cancer	1.85e-06	2.25e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—CYP2C19—prostate cancer	1.84e-06	2.24e-05	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—PIK3CG—prostate cancer	1.83e-06	2.23e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—GSTT1—prostate cancer	1.8e-06	2.19e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—ACHE—prostate cancer	1.8e-06	2.19e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—GGT1—prostate cancer	1.8e-06	2.19e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—CYP2A6—prostate cancer	1.78e-06	2.16e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—TYMS—prostate cancer	1.77e-06	2.15e-05	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—INS—prostate cancer	1.77e-06	2.15e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—NCOA1—prostate cancer	1.77e-06	2.15e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—GSTM1—prostate cancer	1.75e-06	2.13e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—CYP19A1—prostate cancer	1.75e-06	2.12e-05	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—CREBBP—prostate cancer	1.74e-06	2.11e-05	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—INS—prostate cancer	1.74e-06	2.11e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—AKR1C3—prostate cancer	1.73e-06	2.1e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—PRKACB—prostate cancer	1.72e-06	2.09e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—LPL—prostate cancer	1.72e-06	2.09e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—CYP17A1—prostate cancer	1.7e-06	2.07e-05	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—CREBBP—prostate cancer	1.7e-06	2.07e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—RXRA—prostate cancer	1.69e-06	2.05e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—CYP1A1—prostate cancer	1.66e-06	2.02e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—ERCC2—prostate cancer	1.65e-06	2e-05	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—PIK3CD—prostate cancer	1.65e-06	2e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	1.64e-06	1.99e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—COMT—prostate cancer	1.62e-06	1.97e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—NCOA2—prostate cancer	1.62e-06	1.97e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—GSTP1—prostate cancer	1.62e-06	1.96e-05	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—PIK3CD—prostate cancer	1.61e-06	1.96e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—ITPR1—prostate cancer	1.59e-06	1.93e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.56e-06	1.9e-05	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—NOS3—prostate cancer	1.55e-06	1.89e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—MTHFR—prostate cancer	1.55e-06	1.88e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—SLC5A5—prostate cancer	1.55e-06	1.88e-05	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—NOS3—prostate cancer	1.52e-06	1.85e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—PPARA—prostate cancer	1.52e-06	1.85e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—CYP2E1—prostate cancer	1.51e-06	1.84e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—TYMS—prostate cancer	1.5e-06	1.83e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—NQO1—prostate cancer	1.49e-06	1.82e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—GSTM1—prostate cancer	1.48e-06	1.8e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—TH—prostate cancer	1.47e-06	1.79e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—LPL—prostate cancer	1.46e-06	1.77e-05	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—PIK3CB—prostate cancer	1.43e-06	1.74e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—CYP1B1—prostate cancer	1.43e-06	1.74e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—CAV1—prostate cancer	1.43e-06	1.74e-05	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—PTGS2—prostate cancer	1.42e-06	1.73e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—CYP1A1—prostate cancer	1.41e-06	1.71e-05	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—PIK3CB—prostate cancer	1.41e-06	1.71e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—ERCC2—prostate cancer	1.4e-06	1.7e-05	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—PTGS2—prostate cancer	1.39e-06	1.69e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—GGT1—prostate cancer	1.39e-06	1.69e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—NCOA1—prostate cancer	1.37e-06	1.66e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—CYP19A1—prostate cancer	1.35e-06	1.64e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—MTHFR—prostate cancer	1.31e-06	1.59e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—PIK3CG—prostate cancer	1.3e-06	1.58e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—RXRA—prostate cancer	1.3e-06	1.58e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—PPARA—prostate cancer	1.29e-06	1.56e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—COMT—prostate cancer	1.25e-06	1.52e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—GSTP1—prostate cancer	1.25e-06	1.52e-05	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—PTEN—prostate cancer	1.24e-06	1.51e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—INS—prostate cancer	1.23e-06	1.5e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—ITPR1—prostate cancer	1.23e-06	1.49e-05	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—PTEN—prostate cancer	1.21e-06	1.48e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—CAV1—prostate cancer	1.21e-06	1.47e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—CREBBP—prostate cancer	1.21e-06	1.47e-05	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—EP300—prostate cancer	1.18e-06	1.44e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—TYMS—prostate cancer	1.16e-06	1.41e-05	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—EP300—prostate cancer	1.16e-06	1.41e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.16e-06	1.41e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—GSTM1—prostate cancer	1.15e-06	1.39e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—PIK3CD—prostate cancer	1.14e-06	1.39e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—LPL—prostate cancer	1.12e-06	1.37e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—PIK3CG—prostate cancer	1.1e-06	1.34e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—CYP1A1—prostate cancer	1.09e-06	1.32e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—NOS3—prostate cancer	1.08e-06	1.31e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—ERCC2—prostate cancer	1.08e-06	1.31e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—INS—prostate cancer	1.04e-06	1.27e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—CREBBP—prostate cancer	1.02e-06	1.24e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—MTHFR—prostate cancer	1.01e-06	1.23e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—PIK3CB—prostate cancer	9.97e-07	1.21e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—PPARA—prostate cancer	9.93e-07	1.21e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—PTGS2—prostate cancer	9.88e-07	1.2e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—PIK3CD—prostate cancer	9.69e-07	1.18e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—CAV1—prostate cancer	9.34e-07	1.14e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—NOS3—prostate cancer	9.15e-07	1.11e-05	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—PIK3CA—prostate cancer	8.75e-07	1.06e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—PTEN—prostate cancer	8.62e-07	1.05e-05	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—PIK3CA—prostate cancer	8.57e-07	1.04e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—PIK3CG—prostate cancer	8.51e-07	1.03e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—PIK3CB—prostate cancer	8.45e-07	1.03e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—PTGS2—prostate cancer	8.37e-07	1.02e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—EP300—prostate cancer	8.22e-07	9.99e-06	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—INS—prostate cancer	8.05e-07	9.79e-06	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—CREBBP—prostate cancer	7.89e-07	9.59e-06	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—PIK3CD—prostate cancer	7.48e-07	9.09e-06	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—PTEN—prostate cancer	7.3e-07	8.87e-06	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—AKT1—prostate cancer	7.14e-07	8.68e-06	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—NOS3—prostate cancer	7.06e-07	8.58e-06	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—AKT1—prostate cancer	7e-07	8.5e-06	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—EP300—prostate cancer	6.96e-07	8.46e-06	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—PIK3CB—prostate cancer	6.52e-07	7.92e-06	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—PTGS2—prostate cancer	6.46e-07	7.85e-06	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—PIK3CA—prostate cancer	6.08e-07	7.39e-06	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—PTEN—prostate cancer	5.63e-07	6.85e-06	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—EP300—prostate cancer	5.37e-07	6.53e-06	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—PIK3CA—prostate cancer	5.15e-07	6.26e-06	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—AKT1—prostate cancer	4.97e-07	6.03e-06	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—AKT1—prostate cancer	4.21e-07	5.11e-06	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—PIK3CA—prostate cancer	3.97e-07	4.83e-06	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—AKT1—prostate cancer	3.25e-07	3.95e-06	CbGpPWpGaD
